[Acute heart failure (AHF)]

Area of Science:

• Cardiology
• Internal Medicine
• Emergency Medicine

Background:

• Acute heart failure (AHF) presents frequently in emergency settings, associated with prolonged hospital stays, high mortality, and rehospitalization rates.
• The initial months post-hospitalization represent a critical 'vulnerable phase' with elevated risks.
• Limited therapeutic advances in AHF treatment over recent decades, with diuretics and vasodilators showing minimal impact on mortality and rehospitalization.

Purpose of the Study:

• To discuss principles for optimizing and personalizing diuretic therapy and oral heart failure medications.
• To improve patient prognosis during the vulnerable phase following acute heart failure hospitalization.
• To highlight an integrative treatment approach for acute heart failure.

Main Methods:

• Review of current treatment strategies for acute heart failure.
• Discussion on the rapid and intensive up-titration of oral heart failure medical therapy.
• Focus on optimizing diuretic therapy and oral heart failure medications during hospitalization and early outpatient phases.

Main Results:

• Recent findings suggest rapid, intensive oral heart failure medication titration improves prognosis post-AHF.
• An integrative approach combining congestion management with specific therapies is crucial.
• Personalized diuretic and oral medication strategies are key for managing AHF.

Conclusions:

• Optimizing and personalizing medical therapy, including diuretics and oral heart failure drugs, is essential for improving outcomes in AHF.
• Intensive medication titration during and after hospitalization can mitigate risks during the vulnerable phase.
• An integrative management strategy is fundamental for addressing AHF complexity.